Search Browse Earnings

ADIAL PHARMACEUTICALS, INC. — SlamSEC

ADIAL PHARMACEUTICALS, INC.

Nasdaq:ADIL

Pharmaceutical Preparations·CHARLOTTESVILLE, VA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$13.2M

FY 2025

EPS (Diluted)

-$68.01

FY 2025

Stock Price

$1.97

+8.2%

2026-03-11

52W Range

$1.54 – $30.25

P/E Ratio

-0.0x

Market Cap

$2.8M

Cash

$3.8M

FY 2025

Total Debt

—

Net Cash

$3.8M

Enterprise Value

-$937,424.1

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Claiborne Cary J

CFO

Shah Vinay